×
About 19,950 results
ATS Conference 2019 - American Thoracic Society
http://conference.thoracic.org/

May 14th, 2019 - The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders.

Prescription Drug Use in the United States, 2015–2016
https://www.cdc.gov/nchs/products/databriefs/db334.htm
Martin. C., et al

May 8th, 2019 - In 2015–2016, 45.8% of the U.S. population used prescription drugs in the past 30 days. Prescription drug use increased with age, from 18.0% of children under age 12 years to 85.0% of adults aged 60 and over. Prescription drug use was highest among non-Hispanic white persons followed by non-Hispanic black persons, and lowest among non-Hispanic Asian and Hispanic persons. The most commonly us...

FDA requires stronger warnings about rare but serious incidents related to certain prescription insomnia medicines
https://www.fda.gov/news-events/press-announcements/fda-requires-stronger-warnings-about-rare-serious-incidents-related-certain-prescription-insomnia

Apr 29th, 2019 - The U.S. Food and Drug Administration today announced the agency is requiring a new boxed warning – the agency’s most prominent warning – on certain prescription insomnia drugs to better ensure patients and their health care professionals have the information they need when considering use of these medicines. The boxed warning follows several reports of rare, but serious injuries and deaths res...

National Institute on Alcohol Abuse and Alcoholism - What Is A Standard Drink?
https://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/what-standard-drink

Apr 28th, 2019 - Many people are surprised to learn what counts as a drink. The amount of liquid in your glass, can, or bottle does not necessarily match up to how much alcohol is actually in your drink. Different types of beer, wine, or malt liquor can have very different amounts of alcohol content. For example, many light beers have almost as much alcohol as regular beer – about 85% as much.

National Institute on Alcohol Abuse and Alcoholism - Brochures and Fact Sheets
https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets

Apr 28th, 2019 - This section contains easy-to-read material for the public covering a wide range of alcohol-related topics. Publications listed below are online full text and free of charge unless otherwise noted.

Antioxidant; Camellia sinensis; Free radical; Green tea; Matcha
http://www.cqaimh.org/pdf/tool_phq9.pdf

Apr 18th, 2019 - The PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression.

Public Policy Statement on the Ethical Use of Drug Testing in the Practice of Addiction Medicine
https://www.asam.org/docs/default-source/public-policy-statements/2019-ethical-use-of-drug-testing-in-the-practice-of-addiction-medicine.pdf?sfvrsn=75bb4bc2_4

Apr 16th, 2019 - Drug testing uses a biological sample to detect the presence of drugs and/or drug metabolites in a patient’s body. Drug tests are ordered by physicians in a range of medical specialties, but drug testing has particular utility in addiction practices. In clinical addiction medicine, drug testing can provide the treating clinician with objective information about a patient’s recent substance u...

Direct-to-consumer genetic testing
https://www.ama-assn.org/delivering-care/precision-medicine/direct-consumer-genetic-testing

Apr 2nd, 2019 - Types of DTC genetic tests A broad range of genetic test types are offered DTC, including: Carrier testing for diseases such as cystic fibrosis and hemochromatosis Pharmacogenomic testing Testing for predisposition to complex diseases such as hereditary cancers, cardiovascular disease and depression Whole exome or genome sequencing Testing to determine ancestry

ACOG: Sexual Assault
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Health-Care-for-Underserved-Women/Sexual-Assault

Mar 31st, 2019 - Sexual violence continues to be a major public health problem affecting millions of adults and children in the United States. Medical consequences of sexual assault include sexually transmitted infections; mental health conditions, including posttraumatic stress disorder; and risk of unintended pregnancy in reproductive-aged survivors of sexual assault. Obstetrician–gynecologists and other wom...

World Autism Awareness Day 2 April
https://www.un.org/en/events/autismday/index.shtml

Mar 31st, 2019 - On World Autism Awareness Day, we speak out against discrimination, celebrate the diversity of our global community and strengthen our commitment to the full inclusion and participation of people with autism. Supporting them to achieve their full potential is a vital part of our efforts to uphold the core promise of the 2030 Agenda for Sustainable Development: to leave no one behind

Autism Spectrum Disorder (ASD) | Autism | NCBDDD | CDC
https://www.cdc.gov/ncbddd/autism/index.html

Mar 31st, 2019 - Autism Spectrum Disorder (ASD) is a developmental disability that can cause significant social, communication and behavioral challenges. CDC is working to find out how many children have ASD, discover the risk factors, and raise awareness of the signs.

Alcohol Awareness Month – April 2019
https://www.facingaddiction.org/resources/alcohol-awareness-month

Mar 31st, 2019 - Alcohol Awareness Month was established in 1987 to help reduce the stigma so often associated with alcohol addiction by encouraging communities to reach out.

Association of Neuropathologically Confirmed Frontotemporal Dementia and Alzheimer Disease With Criminal and Socially Inappropriate Behavior in a Swedish Cohort
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2729467
Liljegren, M. et. al.

Mar 28th, 2019 - Question Is criminal and socially inappropriate behavior more common among patients with frontotemporal dementia than in those with Alzheimer disease, and is a certain type of protein pathology associated with criminal behavior in patients with frontotemporal dementia? Findings This cohort study of 220 Swedish patients with neuropathologically verified frontotemporal dementia or Alzheimer ...

The CBD boom is way ahead of the science
https://www.sciencenews.org/article/cbd-product-boom-science-research-hemp-marijuana

Mar 26th, 2019 - A few months back, a new storefront appeared in my small Oregon town. Its shelves were packed with tinctures, jars of salve, coffee beans, bath bombs — even beard oil. This motley collection shared a single star ingredient: CBD. Produced by the cannabis plant, CBD is the straitlaced cousin of marijuana’s more famous component — the THC that delivers a mind-swirling high. CBD, or cannabidiol,...

Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
https://investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-announces-us-fda-approval-sunositm

Mar 19th, 2019 - Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved Sunosi™ (solriamfetol) to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). Once-daily Sunosi is approved with doses of 75 mg and 150 mg for patients with narcolepsy and doses of 37.5 mg, 75 mg, and 1...

Sage Therapeutics Announces FDA Approval of ZULRESSO™ (brexanolone) Injection, the First and Only Treatment Specifically Indicated for Postpartum Depression
https://investor.sagerx.com/news-releases/news-release-details/sage-therapeutics-announces-fda-approval-zulressotm-brexanolone

Mar 18th, 2019 - Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, announced today the U.S. Food and Drug Administration (FDA) has approved ZULRESSOTM (brexanolone) injection for the treatment of postpartum depression (PPD). ZULRESSO is the first and only medicine specifically approved to treat PPD, the most co...

Adhansia XR Approved for the Treatment of Pediatric, Adult ADHD
https://www.empr.com/home/news/adhansia-xr-approved-for-the-treatment-of-pediatric-adult-adhd/

Feb 28th, 2019 - The Food and Drug Administration (FDA) has approved Adhansia XR (methylphenidate HCl extended-release; Adlon Therapeutics), a central nervous system stimulant, for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years and older. The approval of Adhansia XR was based on data from 4 clinical trials evaluating the safety and efficacy of the treatment in adult and ...

NIH HEAL Initiative
https://www.nih.gov/research-training/medical-research-initiatives/heal-initiative

Feb 24th, 2019 - In April 2018, NIH launched the HEAL (Helping to End Addiction Long-termSM) Initiative, an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis. This Initiative will build on extensive, well-established NIH research, including basic science of the complex neurological pathways involved in pain and addiction, implementation science to dev...

Sleep Problems in 2- to 5-Year-Olds With Autism Spectrum Disorder and Other Developmental Delays
http://pediatrics.aappublications.org/content/early/2019/02/07/peds.2018-0492
Reynolds, A.

Feb 10th, 2019 - Sleep problems can impact daytime behavior, quality of life, and overall health. We compared sleep habits in young children with autism spectrum disorder (ASD) and other developmental delays and disorders and in children from the general population (POP). We included 2- to 5-year-old children whose parent completed all items on the Children’s Sleep Habits Questionnaire (CSHQ) in a multisite cas...

Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label study
https://www.sciencedirect.com/science/article/pii/S0920996419300416?via%3Dihub
Miller, B. et. al.

Feb 6th, 2019 - We assessed the effectiveness of switching from paliperidone palmitate (PP) or risperidone long-acting injection (RLAI) to aripiprazole lauroxil (AL). Prospective, 6-month study in patients with schizophrenia with residual symptoms or intolerance with PP/RLAI. Effectiveness assessed via all-cause and medication-related discontinuation; CGI-S/BPRS and adverse event monitoring assessed efficacy/t...